Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

34.10

0.00 (0.00%)

At close: Sep 4, 2026, 4:00 PM EDT

34.18

+0.08 (0.23%)

Pre-market: Sep 8, 2026, 8:15 AM EDT

Amylyx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,280	1,327	257	994	2,448	-
Market Cap Growth	387.80%	415.49%	-74.11%	-59.40%	-	-
Enterprise Value	4,034	989	26	644	2,292	-
Last Close Price	34.10	12.08	3.78	14.72	36.95	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	20.17	-	-
Forward PE	-	6.87	6.87	16.68	-	-
PS Ratio	-	-	2.95	2.61	110.13	-
PB Ratio	15.88	4.35	1.56	2.29	7.19	-
P/TBV Ratio	17.90	4.35	1.56	2.29	7.19	-
P/FCF Ratio	-	-	-	93.08	-	-
P/OCF Ratio	-	-	-	83.39	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	-	0.29	1.69	103.12	-
EV/EBITDA Ratio	-	-	-	16.13	-	-
EV/EBIT Ratio	-	-	-	16.59	-	-
EV/FCF Ratio	-	-	-	60.27	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.02	-
Debt / EBITDA Ratio	-	-	-	0.10	-	-
Debt / FCF Ratio	-	-	-	0.40	-	-
Net Debt / Equity Ratio	-1.03	-1.02	-1.06	-0.85	-1.00	-1.09
Net Debt / EBITDA Ratio	1.52	2.04	0.69	-9.20	1.70	1.16
Net Debt / FCF Ratio	1.94	2.52	0.86	-34.38	1.87	1.28
Asset Turnover	-	-	0.25	0.84	0.09	0.01
Inventory Turnover	-	-	-	6.39	-	-
Quick Ratio	11.88	13.98	6.23	5.02	7.78	5.53
Current Ratio	12.12	14.27	6.67	5.66	8.20	6.03
Return on Equity (ROE)	-74.73%	-61.59%	-100.88%	12.73%	-92.53%	-188.05%
Return on Assets (ROA)	-44.13%	-36.41%	-44.95%	5.34%	-50.63%	-86.34%
Return on Invested Capital (ROIC)	-	-	-904.22%	106.30%	-	-
Return on Capital Employed (ROCE)	-66.60%	-49.50%	-154.70%	8.90%	-58.40%	-93.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-3.55%	-10.91%	-117.25%	4.96%	-8.10%	-
FCF Yield	-2.96%	-9.31%	-79.27%	1.07%	-7.45%	-
Buyback Yield / Dilution	-36.47%	-38.78%	2.64%	-19.65%	-788.13%	-8.37%

SEC Filings: 10-K · 10-Q